Drug Research

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing and research collaboration with Bristol Myers Squibb focused on the discovery, development and commercialization...

Almac Discovery and Queen’s University Belfast reported a five-year project to develop a new Chemoproteomics Centre of Excellence for drug discovery. The multi-million-pound facility, which is jointly funded by Almac Discovery and a BBSRC Prosperity Partnership award, is a...

Berry Global will demonstrate its commitment to delivering innovative, patient-centric packaging, dispensing solutions, and drug delivery devices for India and the South Asia region on the company’s stand at this year’s CPHI India exhibition. Berry will showcase a wide range...

Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development...

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more than 20% between 2023 and 2030. This progress is driven, in part, by the increasing...

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that have already been authorized in certain overseas territories. The changes made by NPRA go on...

Market-leading commercialization platform, Inizio, has announced ‘Inizio Launch Elevate’, a connected suite of its best-in-class capabilities designed to accelerate and simplify product launches for global pharma and biotech companies. Inizio Launch Elevate combines deep market and patient insights, launch strategy...